Table III.
0 (n=19) | T/K (n=18) | O+T/K (n=18) | Control (n=20) | pa | |
---|---|---|---|---|---|
Start intervention | |||||
PMA (weeks) | 32.7 (0.3) | 32.1 (0.3) | 31.7 (0.4) | 32.5 (0.3) | 0.079 |
DOL (days) | 23.4 (3.8) | 24.3 (4.1) | 19.6 (3.5) | 23.0 (4.1) | 0.851 |
Weight (g) | 1676.3 (64.5) | 1673.4 (55.7) | 1615.8 (67.7) | 1709.5 (63.6) | 0.742 |
End intervention | |||||
PMA (wk) | 34.3 (0.3) | 33.6 (0.2) | 33.1 (0.2) | 34.0 (0.1) | 0.072 |
DOL (d) | 33.8 (3.8) | 35.1 (2.8) | 30.3 (2.0) | 33.6 (2.0) | 0.854 |
Weight (g) | 1987.4 (66.9) | 1994.2 (49.2) | 1905.0 (42.6) | 2000.0 (38.9) | 0.749 |
Episodes of apnoea, bradycardia, or oxygen desaturation | 4 | 4 | 5 | 0 | 0.205 |
Episodes of fussy/crying/spitting up | 0 | 0 | 0 | 0 | 1.000 |
Data presented as means (standard error of mean) or number of participants.
Analysis of variance (ANOVA) unless otherwise indicated.
Fisher's exact test. O, oral; T/K, tactile/kinaesthetic; PMA, postmenstrual age; DOL, days of life.